Funding for Innovation & Growth
The strongest funding opportunities are built around work the company already needs to execute: developing technology, generating evidence, achieving regulatory milestones, industrializing a product or preparing for market growth.
We contribute practically to shaping the initiative, including areas such as regulatory strategy, evidence planning, work packages, resources and partner alignment.
We help shape those priorities into credible, fundable programs while keeping the funded project aligned with the company's real objectives.
Where we bring distinctive experience.
Direct program experience meets deep Medtech execution capability.
EIC Accelerator
For whom: Start-ups and SMEs developing breakthrough innovations with strong scale-up potential.
Stage: TRL 6–8, from advanced development and validation toward commercialisation and scale-up.
EIT Health
For whom: European healthcare start-ups, SMEs and innovators in Medtech, biotech, digital health, AI and diagnostics.
Stage: Product development and validation through commercialisation and market adoption, depending on the call.
Innosuisse
For whom: Swiss start-ups, SMEs and research–industry collaborations developing science-based innovations.
Stage: From product development and validation to market entry and commercialisation, depending on the instrument.
A combination of evaluator insight, funding experience and practical Medtech leadership.
Evaluator perspective
First-hand experience evaluating European innovation and healthcare funding proposals.
Funding experience
Practical experience structuring, obtaining and working with non-dilutive innovation funding.
Medtech execution
More than 18 years across R&D, clinical evidence, regulatory affairs, quality, operations and program leadership.
Identifying the right European and Swiss opportunities for you
Not every initiative belongs in the same program. We can assess other European and Swiss funding opportunities when they provide a better fit with the company's objectives, development stage and planned activities.
Funding is useful only when the funded initiative can be executed and contribute to the company's objectives.
Assess
Evaluate the strategic fit between the initiative, the company and available funding opportunities.
Frame
Translate business and development priorities into a coherent, fundable project.
Build
Align technology, evidence, regulatory strategy, work packages, resources, partners and business case.
Execute
Support or lead implementation after funding, keeping the project connected to the intended business outcome.
Built on real MedTech development experience.
Our funding expertise is backed by hands-on experience developing medical technology and generating the scientific evidence needed to support its claims.
Our Technology
First-hand experience developing proprietary medical-device technology, connecting innovation with engineering, regulatory requirements and clinical needs.
Explore Our Technology →Evidence Creation
Experience translating scientific questions into biomechanical, preclinical and clinical evidence to support product claims and development decisions.
Evidence for Claims Strategy →Could external funding accelerate a critical initiative?
Discuss the initiative directly with the person who would lead the engagement. Together, we can determine whether funding fits what your company already needs to achieve.
Looking for a Medtech partner for your European project?
Bring Biomech Innovations into the consortium.
European projects need more than a strong scientific concept. They require product-development thinking, regulatory strategy, clinical and preclinical evidence, project execution and a credible route to implementation and market adoption.
Biomech Innovations can participate as a project partner, bringing cross-functional Medtech expertise into the consortium and taking ownership of defined work packages or project activities.
What we can bring to the consortium
- Medical-device development strategy
- Regulatory strategy
- Preclinical & clinical evidence
- Project & program management
- Risk and development planning
- Exploitation & commercialization strategy
- Cross-functional Medtech execution